Selected article for: "magnetic resonance imaging and resonance imaging"
Author: Huayan Xu; Keke Hou; Hong Xu; Zhenlin Li; Huizhu Chen; Na Zhang; Rong Xu; Hang Fu; Ran Sun; Lingyi Wen; Linjun Xie; Hui Liu; Kun Zhang; Joseph B Selvanayagam; Chuan Fu; Shihua Zhao; Zhigang Yang; Ming Yang; Yingkun Guo
Title: Acute Myocardial Injury of Patients with Coronavirus Disease 2019
  • Document date: 2020_3_8
    • ID: jg6v644y_47
    Snippet: Our study has some limitations. First, this is a modest-size case series of hospitalized COVID-19 patients; more standardized data from a larger cohort would beneficial for further determining the clinical characteristics. Second, our data showed the clinical characteristics of AMI induced by COVID-19, including the clinical presentations, electrophysiological abnormality, myocardial enzyme and myocardial injury marker levels, and cardiac dysfunc.....
    Document: Our study has some limitations. First, this is a modest-size case series of hospitalized COVID-19 patients; more standardized data from a larger cohort would beneficial for further determining the clinical characteristics. Second, our data showed the clinical characteristics of AMI induced by COVID-19, including the clinical presentations, electrophysiological abnormality, myocardial enzyme and myocardial injury marker levels, and cardiac dysfunction and enlargement. However, the tissue characteristics in myocardial damage (i.e., edema, fibrosis, and microcirculation disorder) should be further demonstrated via cardiac magnetic resonance imaging examination as far as possible under the premise of controlling transmission. Finally, most of the COVID-19 patients with AMI had severe or critically severe NCP and high fatality rate, but long-term follow-up should be performed to determine adverse cardiac All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cardiac dysfunction and clinical presentation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cardiac dysfunction and high fatality: 1
    • cardiac dysfunction and high fatality rate: 1
    • cardiac dysfunction and large cohort: 1, 2, 3, 4
    • cardiac dysfunction and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
    • cardiac dysfunction and long term follow: 1, 2, 3, 4
    • cardiac dysfunction and magnetic resonance imaging examination: 1
    • cardiac dysfunction and myocardial damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cardiac dysfunction and myocardial enzyme: 1, 2, 3, 4
    • cardiac dysfunction and resonance imaging: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cardiac dysfunction and resonance imaging examination: 1
    • cardiac magnetic resonance imaging examination and magnetic resonance imaging examination: 1, 2, 3
    • cardiac magnetic resonance imaging examination and resonance imaging: 1, 2, 3
    • cardiac magnetic resonance imaging examination and resonance imaging examination: 1, 2, 3
    • clinical characteristic and high fatality: 1